Kelun Pharmaceutical has spared no effort to build innovative pharmaceutical enterprises for a long time, trained and introduced a group of academic leaders with high academic attainments, and has now established an efficient innovation team. At the same time, R&D's investment has been continuously strengthened, and the strength of shopping malls has become stronger and stronger. Scientific and technological innovation is Koren's core competitiveness. Kelun Pharmaceutical established Chengdu Kelun Pharmaceutical Research Institute as early as 1998 (renamed Sichuan Kelun Pharmaceutical Research Co., Ltd. on June +0, 2007), specializing in drug research and development and technology transfer. It is an independent legal entity under Sichuan Kelun Pharmaceutical Co., Ltd., as a research and development center, directly relying on Kelun Pharmaceutical National Postdoctoral Research Center. By the end of February, 20 1 1 and 65438+,* * had obtained 8 new drug certificates and applied for 5 19 patents, including 92 invention patents.
On June 30, 2009, 10, the Ministry of Science and Technology approved Kelun Pharmaceutical to establish the National Large-capacity Injection Engineering Technology Research Center; On June 6th, 2009, 165438+ was jointly recognized as the National Enterprise Technology Center by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs and State Taxation Administration of The People's Republic of China. Enterprise academician workstation was established on 20 1 1. Has a standard laboratory of 3000m2; There are 4 pilot workshops with a production capacity of 4500m2, including large-capacity injections in glass bottles, large-capacity injections in plastic bottles, small-capacity injections and freeze-dried powder injections (all of which have passed SFDA GMP certification); It has 446 sets of experimental research and pilot equipment with an original value of 64.58 million. It can undertake the research and development, pilot test and pilot test of various new drugs, which provides favorable conditions for the experimental development of new products.
Kelun pays attention to the research and development of innovative drugs, focusing on the development of a class of new drugs in the fields of antibacterial, antiviral, antitumor, treatment of mental illness, and treatment of cardiovascular and cerebrovascular diseases. At present, there are 8 new drugs independently developed and jointly developed.
Kelun has now formed a variety of dosage forms, focusing on the development of large infusion, while developing raw materials, tablets, capsules, granules, dripping pills, eye drops, ear drops, mixtures, small-volume injections, powder injections, traditional Chinese medicine injections and so on. It is a new drug research and development institution with strong R&D strength and advanced supporting equipment in western China. Kelun Pharmaceutical Co., Ltd. actively cooperates with Industry-University-Research. The company has carried out extensive exchanges and cooperation with universities and research institutes at home and abroad, formed a strategic partnership of knowledge alliance, and further enhanced its research and development strength. With Peking University, China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan University, Second Military Medical University, Jiangxi College of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Sichuan Academy of Traditional Chinese Medicine, Sichuan Institute of Antibiotic Industry, Frontier Laboratory Co., Ltd. and other more than 20 domestic and foreign pharmaceutical research institutions, we have established extensive, in-depth and long-term cooperative relations.
scope of business
Research and development of new drugs, generic drugs and technology for the company's subordinate enterprises.
Accept the research and development work entrusted by other units.
Research and development direction
Develop infusion varieties with good market prospects.
Research and development of new infusion packaging
Develop OTC products with definite curative effect and low toxic and side effects.
Develop brand-new drugs with independent intellectual property rights
Develop new pharmaceutical dosage forms
Develop a new compound preparation
The second is to develop the existing famous and excellent Chinese patent medicine products and promote the modernization of Chinese medicine.